Real-time enrollment status for this gastroesophageal cancer clinical trial
Current Status
Active, Not Recruiting
Checked: March 2, 2026 at 11:51 AM UTC
| NCT Number | NCT06356311 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Gastroesophageal Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 450 participants |
| Active Locations | 17 sites in the US |
| Sponsor | Merck Sharp & Dohme LLC |
| Last Updated on CT.gov | February 27, 2026 (3 days ago) |
As of March 2, 2026: Clinical trial NCT06356311 is currently active_not_recruiting participants. This clinical trial study for gastroesophageal cancer is not currently accepting new participants at 17 locations across the United States. The study is sponsored by Merck Sharp & Dohme LLC. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT06356311 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 17 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06356311 was last updated 3 days ago (February 27, 2026). HelloStudys verifies this status automatically.